Pharmaceuticals

Latest 天天看片 Health News Stories

Harris and Trump Are Ready To Take on Big Pharma

天天看片 Health News Original

Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California鈥檚 attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United […]

Copycat Weight-Loss Drugs Are Major Players With Consumers

天天看片 Health News Original

As many as 1 in 8 American adults has tried one of the GLP-1 anti-obesity drugs, but a surprising number aren鈥檛 getting their supplies from pharma giants Novo Nordisk or Eli Lilly. Up to 30 percent of the market, by some estimates, is made up of copycat versions from compounding pharmacies. Compounding is legal, though […]

天天看片 Health News' 'What the Health?': Harris in the Spotlight

Podcast

For the 2024 campaign, Joe Biden is out, and Kamala Harris is in. As the vice president makes moves toward the top of the Democratic presidential ticket, health policy is resurging as a campaign issue. Meanwhile, Congress tries 鈥 and again fails 鈥 to make timely progress on the annual government spending bills as abortion issues cause delays. Alice Miranda Ollstein of Politico, Stephanie Armour of 天天看片 Health News, and Rachel Cohrs Zhang of Stat join 天天看片 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Anthony Wright, the new executive director of Families USA, about his plans for the organization and his history working with Harris on health topics.鈥

The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.

天天看片 Health News Original

A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation 鈥 with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law 鈥 could leave the country with a patchwork of disparate health regulations.

天天看片 Health News' 'What the Health?': SCOTUS Rejects Abortion Pill Challenge 鈥 For Now聽

Podcast

The Supreme Court has dismissed a challenge to the FDA鈥檚 approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of 天天看片 Health News, and Emmarie Huetteman of 天天看片 Health News join 天天看片 Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF鈥檚 new 鈥淗ealth Policy 101鈥 primer.

Weight-Loss Drugs Are So Popular They鈥檙e Headed for Medicare Negotiations

天天看片 Health News Original

The steep prices 鈥 and popularity 鈥 of Ozempic and similar weight-loss and diabetes drugs could soon make them a priority for Medicare drug price negotiations. List prices for a month鈥檚 supply of the drugs range from $936 to $1,349, according to the Peterson-天天看片 Health System Tracker. The Inflation Reduction Act President Biden signed in […]

天天看片 Health News' 'What the Health?': Waiting for SCOTUS

Podcast

June is when the Supreme Court typically issues rulings in the major cases it hears during that year鈥檚 term. This year, those interested in health policy are awaiting decisions in two abortion-related cases and one that could reshuffle the way health policies (and all other federal policies) are made. In this special episode, KFF鈥檚 Laurie Sobel, associate director for women鈥檚 health policy, joins Julie Rovner for a review of the cases and a preview of how the court might rule.